Clostridium difficile 30 years on: what has, or has not, changed and why?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0924-8579(09)70008-1PMID 19303564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clindamycin-associated colitis

  2020cited by this paper
• A case-control study of community-associated Clostridium difficile infection.

  2008cited by this paper
• Surveillance for community-associated Clostridium difficile--Connecticut, 2006.

  2008cited by this paper
• Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection

  2008cited by this paper
• Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea.

  2007cited by this paper
• Clostridium difficile toxin expression is inhibited by the novel regulator TcdC

  2007cited by this paper
• A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

  2007cited by this paper
• Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

  2007cited by this paper
• Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.

  2007cited by this paper
• Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy

  2006cited by this paper
• Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin

  2006cited by this paper
• Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

  2005cited by this paper
• Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

  2005cited by this paper
• An epidemic, toxin gene-variant strain of Clostridium difficile.

  2005cited by this paper
• Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

  2005cited by this paper
• Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.

  2005cited by this paper
• Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture.

  2005cited by this paper
• Effect of yogurt on clindamycin-inducedClostridium difficile colitis in hamsters

  2005cited by this paper
• A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

  2005cited by this paper
• Human antibody response to surface layer proteins in Clostridium difficile infection.

  2004cited by this paper
• Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B

  2004cited by this paper
• Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

  2003cited by this paper
• Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

  2001cited by this paper
• Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor

  2001cited by this paper
• Evaluation of Methods for Detection of Toxins in Specimens of Feces Submitted for Diagnosis of Clostridium difficile- Associated Diarrhea

  2001cited by this paper
• The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.

  2000cited by this paper
• Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

  2000cited by this paper
• Characterization of a Toxin A-Negative, Toxin B-Positive Strain of Clostridium difficile Responsible for a Nosocomial Outbreak of Clostridium difficile-Associated Diarrhea

  2000cited by this paper
• Environmental control to reduce transmission of Clostridium difficile.

  2000cited by this paper
• Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

  1999cited by this paper
• Serum Antitoxin Antibodies Mediate Systemic and Mucosal Protection from Clostridium difficileDisease in Hamsters

  1999cited by this paper
• The epidemiology and typing of Clostridium difficile.

  1998cited by this paper
• Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.

  1998cited by this paper
• Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile.

  1997cited by this paper
• Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

  1997cited by this paper
• Transcriptional analysis of the toxigenic element of Clostridium difficile.

  1997cited by this paper
• The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile.

  1995cited by this paper
• Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

  1995cited by this paper
• Glucosylation of Rho proteins by Clostridium difficile toxin B

  1995cited by this paper
• Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters

  1995cited by this paper
• Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use

  1994cited by this paper
• Wide diversity of Clostridium difficile types at a tertiary referral hospital.

  1994cited by this paper
• Epidemiology of community-acquired Clostridium difficile-associated diarrhea.

  1994cited by this paper
• Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction.

  1993cited by this paper
• Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems

  1993cited by this paper
• Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

  1992cited by this paper
• Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.

  1992cited by this paper
• Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole

  1992cited by this paper
• Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables.

  1992cited by this paper
• Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.

  1992cited by this paper
• Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase

  1991cited by this paper
• Nosocomial Clostridium difficile colonisation and disease.

  1990cited by this paper
• Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

  1990cited by this paper
• Molecular characterization of the Clostridium difficile toxin A gene

  1990cited by this paper
• Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

  1989cited by this paper
• Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens.

  1989cited by this paper
• Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.

  1989cited by this paper
• Bacteriotherapy for chronic relapsing Clostridium difficile in six patients

  1989cited by this paper
• Nosocomial acquisition of Clostridium difficile infection.

  1989cited by this paper
• Clostridium difficile: its role in intestinal disease continued.

  1988cited by this paper
• Treatment of relapsingClostridium difficile diarrhoea by administration of a non-toxigenic strain

  1987cited by this paper
• Beta-lactams and imipenem.

  1986cited by this paper
• Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.

  1986cited by this paper
• Serum antibody response to clostridium difficile toxins in patients with clostridium difficile diarrhoea

  1985cited by this paper
• Effects of Clostridium difficile toxins given intragastrically to animals

  1985cited by this paper
• Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A

  1985cited by this paper
• Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains.

  1985cited by this paper
• Enzyme-linked immunosorbent assay for Clostridium difficile toxin A

  1983cited by this paper
• Serum antibody response to toxins A and B of Clostridium difficile.

  1983cited by this paper
• Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

  1983cited by this paper
• Gastroenterostomy for cicatrizing ulcer of the pylorus.

  1983cited by this paper
• Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile.

  1983cited by this paper
• Biological activities of toxins A and B of Clostridium difficile

  1982cited by this paper
• 12 month follow-up of mebendazole therapy for onchocerciasis.

  1981cited by this paper
• Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.

  1981cited by this paper
• Treatment of Clostridium difficile colitis and diarrhea with vancomycin.

  1981cited by this paper
• Epidemiology of experimental enterocecitis due to Clostridium difficile.

  1980cited by this paper
• Selective and differential medium for isolation of Clostridium difficile

  1979cited by this paper
• Contamination of a hospital environment byClostridium difficile

  1979cited by this paper
• Clostridium difficile and the aetiology of pseudomembranous colitis.

  1978cited by this paper
• Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

  1978cited by this paper
• Aetiology of antimicrobial-agent-associated colitis.

  1978cited by this paper
• Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients

  1978cited by this paper
• Pseudomembranous colitis: Presence of clostridial toxin.

  1977cited by this paper
• Undescribed toxin in pseudomembranous colitis.

  1977cited by this paper
• Clindamycin-associated colitis in hamsters: protection with vancomycin.

  1977cited by this paper
• Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

  1977cited by this paper
• The protective effect of vancomycin on clindamycin-induced colitis in hamsters.

  1977cited by this paper
• Clindamycin-Associated Colitis: A Prospective Study

  1974cited by this paper
• Lincomycin as a cause of pseudomembranous colitis.

  1973cited by this paper
• Pseudo-membranous colitis

  1965cited by this paper
• Postoperative pseudomembranous enterocolitis.

  1954cited by this paper
• THE TOXICITY OF PENICILLIN AS PREPARED FOR CLINICAL USE

  1943cited by this paper
• INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS

  1935cited by this paper

• Characterization of High-Linezolid-MIC Clostridioides difficile Isolated from a Chinese Hospital: First Genomic Evidence of Cfr(B) Transmission and Tn6218 Association

  2025cites this paper
• Comparative genomics reveals diversity and taxonomic relationships among Clostridioides difficile phages

  2024cites this paper
• Phage therapy for Clostridioides difficile infection

  2022cites this paper
• Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens

  2022cites this paper
• Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults?

  2021cites this paper
• Selectivity in the Formation of Straight-Chain Versus Cyclised products on Knoevenagel Condensation between Thiobarbituric acid and Naphthaldehydes

  2021cites this paper
• Time to antibiotic administration: Sepsis alerts called in emergency department versus in the field via emergency medical services.

  2020cites this paper
• Scarring Alopecia

  2020cites this paper
• Local outbreak of Clostridioides difficile PCR-Ribotype 018 investigated by multi locus variable number tandem repeat analysis, whole genome multi locus sequence typing and core genome single nucleotide polymorphism typing.

  2019cites this paper
• Antibiotic resistance of clinical isolates of Clostridioides difficile in China and its association with geographical regions and patient age.

  2019cites this paper
• Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4‐year period in China

  2018cites this paper
• Diarreia causada por Clostridium difficile: recentes avanços

  2018influential citation
• A Retrospective Study of Patient Factors That Indicate Provider Nonadherence to an Institutional Clostridium difficile Treatment Guideline

  2018cites this paper
• 292 – Antimicrobial Agents

  2018cites this paper
• The role of trehalose in the global spread of epidemic Clostridium difficile

  2018cites this paper
• Parenterally administered vancomycin in 29 dogs and 7 cats (2003‐2017)

  2018cites this paper
• Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection

  2017cites this paper
• Antibiotic exposure Increased patient age Prior hospitalization Severity of underlying illness Proton pump inhibitors and H 2 blocker use Abdominal operation Nasogastric tube Long duration of hospitalization Long-term care residency IBD Organ transplantation Chemotherapy Chronic kidney disease

  2017cites this paper
• How to: diagnose infection caused by Clostridium difficile.

  2017cites this paper
• Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology.

  2017cites this paper
• Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update.

  2017cites this paper
• Use of the cobas 4800 system for the rapid detection of toxigenic Clostridium difficile and methicillin-resistant Staphylococcus aureus.

  2016cites this paper
• Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.

  2016cites this paper
• Clostridium difficile infection: Early history, diagnosis and molecular strain typing methods.

  2016cites this paper
• [Laboratory diagnosis of Clostridium difficile infection].

  2016cites this paper
• Lactococcus lactis ssp. lactis biovar. diacetylactis UL719 et la nisine : une nouvelle approche dans le traitement des infections à Clostridium difficile

  2015cites this paper
• Identification of Recurrent Clostridium difficile Infection Using Administrative Codes: Accuracy and Implications for Surveillance

  2015cites this paper
• Clostridium difficile infection: a Serbian single-center experience.

  2015cites this paper
• Disproportionate Rise in Clostridium difficile–Associated Hospitalizations Among US Youth With Inflammatory Bowel Disease, 1997–2011

  2015cites this paper
• Molecular characterization of pathogenic Clostridium difficile strains

  2014cites this paper
• Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich

  2014cites this paper
• Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case–control study

  2014cites this paper
• A Review of the Economics of Treating Clostridium difficile Infection

  2014cites this paper
• Clostridium difficile infection in the elderly.

  2014cites this paper
• Pseudomembranous Colitis – a review Colite Pseudomembranosa - uma revisão

  2014cites this paper
• Proteomics in farm animals models of human diseases

  2014cites this paper
• Culturing and maintaining Clostridium difficile in an anaerobic environment.

  2013cites this paper
• Diagnosis of Clostridium difficile infection: the molecular approach.

  2013cites this paper
• A multicenter, double‐blind, randomized, placebo‐controlled study of rifaximin for the treatment of bacterial vaginosis

  2013cites this paper
• Man and pigs: sharing the same C. difficile

  2013cites this paper
• Clostridium difficile infections: do we know the real dimensions of the problem?

  2013cites this paper
• Epidemiology of Clostridium difficile Infection

  2013cites this paper
• Clostridium difficile infection in humans and piglets: a 'One Health' opportunity.

  2013cites this paper
• Combination of culture, antigen and toxin detection, and cytotoxin neutralization assay for optimal Clostridium difficile diagnostic testing.

  2013cites this paper
• Clostridium difficile infection in children: a comprehensive review

  2013cites this paper
• Novel avenues for Clostridium difficile infection drug discovery

  2013cites this paper
• Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis

  2012influential citation
• Clostridium difficile: expression of virulence factors, resistance to disinfectants and interactions with human cells

  2012cites this paper
• Clostridium difficile infection: the next big thing!

  2012cites this paper
• Outcome of Clostridium difficile‐associated disease in solid organ transplant recipients: a prospective and multicentre cohort study

  2012cites this paper
• Temporal Differential Proteomes of Clostridium difficile in the Pig Ileal-Ligated Loop Model

  2012cites this paper
• Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen.

  2012cites this paper
• Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice

  2012cites this paper
• Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile

  2012cites this paper
• [Scarring alopecia].

  2012cites this paper
• Staphylococcus aureus: Emerging Concepts in Vaccine Development

  2011cites this paper
• Extended Multilocus Variable-Number Tandem-Repeat Analysis of Clostridium difficile Correlates Exactly with Ribotyping and Enables Identification of Hospital Transmission

  2011cites this paper
• Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR

  2011cites this paper
• Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine development.

  2011cites this paper
• Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection

  2011cites this paper
• Clostridium difficile infection: epidemiology, risk factors and management

  2011cites this paper
• Evaluation of BD GeneOhm CDiff PCR assay for diagnosis of toxigenic Clostridium difficile infection.

  2010cites this paper
• The food glycome: a source of protection against pathogen colonization in the gastrointestinal tract.

  2010cites this paper